In addition, the proliferation of ACHN and 786-O cells were recovered after treatment with LiCl (a classical agonist of the Wnt signaling pathway) in PRMT2-knockdown RCC cells (Fig. S4A, B). The gene discussed is PRMT2; the disease is renal cell adenocarcinoma.